je.st
news
Tag: actavis
Actavis in $66bn deal for Allergan
2014-11-17 16:52:31| BBC News | Business | UK Edition
Actavis is buying Botox-maker Allergan for $66bn (42bn) to create one of the top ten biggest pharmaceutical companies in the world.
Actavis Beats Q3 Views As Buyout Talk Swirls
2014-11-06 05:57:54| Biotech - Topix.net
Generic and specialty drug giant Actavis beat Wall Street's third-quarter estimates and raised its guidance early Wednesday, sending the stock to a new high of 254.41 before closing up 1.1% at 247.91. ' earnings, excluding one-time items, rose 53% over the year-earlier quarter to $3.19 a share, beating analysts' consensus by 9 cents, according to Thomson Reuters.
Mobileye, Actavis: More Durable Earnings Outlooks
2014-10-15 07:14:14| Auto Parts - Topix.net
Paul Gordon and his MFS Mid Cap Growth colleagues follow the old adage: When you reach the edge of a cliff, remember to fly. That's the strategy used by these midcap managers during the current sell-off, as the stock market continues to punish large-cap stocks less than smaller ones.
Tags: earnings
durable
outlooks
actavis
Exclusive: Top Actavis holder, Fidelity, adds Allergan holdings- sources
2014-10-10 20:10:06| IT Services - Topix.net
The Boston-based investment firm, which collectively owned 3.88 million Allergan shares through several of its funds as of end-June, had added roughly 2 million shares by the end of August, according to Thomson Reuters data based on Fidelity's monthly filings. The additions would likely make Fidelity the No.8 shareholder in Allergan, according to Thomson Reuters data, assuming there was no significant changing of hands in the company's top-10 shareholder base.
Tags: top
sources
exclusive
adds
Exclusive: Top Actavis holder, Fidelity, adds Allergan holdings- sources
2014-10-10 20:09:46| Biotech - Topix.net
The Boston-based investment firm, which collectively owned 3.88 million Allergan shares through several of its funds as of end-June, had added roughly 2 million shares by the end of August, according to Thomson Reuters data based on Fidelity's monthly filings. The additions would likely make Fidelity the No.8 shareholder in Allergan, according to Thomson Reuters data, assuming there was no significant changing of hands in the company's top-10 shareholder base.
Tags: top
sources
exclusive
adds